flunixin meglumine has been researched along with Foot Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergstrom, BE; Coren, DS; Foreman, CR; Foreman, JH; Golden, KS; Roark, JJ; Schumacher, SA | 1 |
Foreman, JH; Ruemmler, R | 1 |
Clarke, CR; Erkert, RS; MacAllister, CG; Payton, ME | 1 |
3 other study(ies) available for flunixin meglumine and Foot Diseases
Article | Year |
---|---|
Dose titration of the clinical efficacy of intravenously administered flunixin meglumine in a reversible model of equine foot lameness.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Dose-Response Relationship, Drug; Foot Diseases; Heart Rate; Horse Diseases; Horses; Lameness, Animal; Pain; Pressure | 2012 |
Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Topics: Animals; Clonixin; Cross-Over Studies; Drug Therapy, Combination; Female; Foot Diseases; Heart Rate; Horse Diseases; Horses; Lameness, Animal; Male; Pain; Phenylbutazone; Time Factors | 2011 |
Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Foot Diseases; Horse Diseases; Horses; Injections, Intravenous; Lameness, Animal; Phenylbutazone; Syndrome; Treatment Outcome | 2005 |